Reportlinker finds all market research
reports published by official sources!

Company Report: Generic Drug in The United States for Year 2011

  • This 23-page company report was published in March 2011.
... as well as 32 967 Generic Drug industry reports, company profiles and country guides published by official sources (government, embassies, trade unions...).

We value your privacy and will never rent or sell your email address. Privacy Policy by TRUSTe

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources


Global Generic Drug Industry : Latest Downloads

Company Report: Generic Drug in Turkey and Italy for Year 2013

  • Company report
  • June 2013
  • 52 pages

... Appendix-2: reference pricing scheme ** the government recently lowered the price ceiling from 15% to 10% for the reimbursement price of generic drugs in the same bioequivalance group (which is applied ...

Company Report: Generic Drug in Turkey and Italy for Year 2013

  • Company report
  • May 2013
  • 52 pages

... Appendix-2: reference pricing scheme ** the government recently lowered the price ceiling from 15% to 10% for the reimbursement price of generic drugs in the same bioequivalance group (which is applied ...

Company Report: Generic Drug for Year 2014

  • Company report
  • February 2014
  • 2 pages

... Enquiries to: website: www.generics-bulletin.Com this article first appeared in generics bulletin issue no. 206, Published on 14 february 2014. Www.generics ...


Related Market Segments :

Generics
Rasagiline

Global Generic Drug Industry : Latest Reports

Italfarmaco S.p.A. SWOT Analysis, Strategy, Revenues and Profits

Italfarmaco S.p.A. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Dexmedetomidine  - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

  • $ 1 300
  • Company report
  • March 2014
  • by Generics Web - Selector 44

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 ...

Liraglutide  - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

Liraglutide - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

  • $ 1 200
  • Company report
  • March 2014
  • by Generics Web - Selector 44

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 ...


Related Market Segments :

Generics
Rasagiline

Company Reports

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.